Abstract
Backgrounds & Aims The aim of this study is to evaluate the prognostic significances of not only the initial and the best response during repeated transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC), but if eligible, also the time point of achieving treatment responses. Methods Three hundred and fourteen treatment-naïve patients with well-preserved liver function undergoing TACE were recruited. Treatment responses were assessed using modified Response Evaluation Criteria in Solid Tumors. Overall survival (OS) was analyzed using Kaplan-Meier methods, and Cox regression analysis was performed for multivariate analysis. Results After adjusting other variables, objective response (complete response [CR] and partial response [PR]) as the initial response (adjusted hazard ratio [HR] 0.410) and the best response (adjusted HR 0.335) had independent prognostic significances for OS, respectively (both p <0.001). Objective responders as the initial response had the longest OS, followed by patients who subsequently achieved objective response after at least two sessions and those who did not achieve objective response during treatment course eventually (52.6, 27.0, and 10.8 months, respectively; log-rank test, p <0.001). Likewise, patients with CR as the initial response had the longest OS, followed by those who subsequently achieved CR after at least two sessions and those who achieved PR as the best response (70.2, 40.6, and 23.0 months, respectively; log-rank test, p <0.001). Large (>5 cm) and multiple (â>4) tumors were independently associated with failure to achieve CR after the initial TACE (both p <0.05). Conclusion Both the initial and the best response predicts OS effectively. However, achievement of treatment response at an early time point is still the most robust predictor for favorable outcomes.
| Original language | English |
|---|---|
| Article number | 5525 |
| Pages (from-to) | 1304-1310 |
| Number of pages | 7 |
| Journal | Journal of Hepatology |
| Volume | 62 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 2015 Jun 1 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Hepatology
Cite this
}
Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma. / Kim, Beom Kyung; Kim, Seungup; Kim, Kyung Ah; Chung, Yong Eun; Kim, Myeong Jin; Park, Mi Suk; Park, Junyong; kim, doyoung; Ahn, SangHoon; Kim, ManDeuk; Park, Sung Il; Won, Jong Yoon; Lee, Do Yun; Han, KwangHyub.
In: Journal of Hepatology, Vol. 62, No. 6, 5525, 01.06.2015, p. 1304-1310.Research output: Contribution to journal › Article
TY - JOUR
T1 - Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma
AU - Kim, Beom Kyung
AU - Kim, Seungup
AU - Kim, Kyung Ah
AU - Chung, Yong Eun
AU - Kim, Myeong Jin
AU - Park, Mi Suk
AU - Park, Junyong
AU - kim, doyoung
AU - Ahn, SangHoon
AU - Kim, ManDeuk
AU - Park, Sung Il
AU - Won, Jong Yoon
AU - Lee, Do Yun
AU - Han, KwangHyub
PY - 2015/6/1
Y1 - 2015/6/1
N2 - Backgrounds & Aims The aim of this study is to evaluate the prognostic significances of not only the initial and the best response during repeated transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC), but if eligible, also the time point of achieving treatment responses. Methods Three hundred and fourteen treatment-naïve patients with well-preserved liver function undergoing TACE were recruited. Treatment responses were assessed using modified Response Evaluation Criteria in Solid Tumors. Overall survival (OS) was analyzed using Kaplan-Meier methods, and Cox regression analysis was performed for multivariate analysis. Results After adjusting other variables, objective response (complete response [CR] and partial response [PR]) as the initial response (adjusted hazard ratio [HR] 0.410) and the best response (adjusted HR 0.335) had independent prognostic significances for OS, respectively (both p <0.001). Objective responders as the initial response had the longest OS, followed by patients who subsequently achieved objective response after at least two sessions and those who did not achieve objective response during treatment course eventually (52.6, 27.0, and 10.8 months, respectively; log-rank test, p <0.001). Likewise, patients with CR as the initial response had the longest OS, followed by those who subsequently achieved CR after at least two sessions and those who achieved PR as the best response (70.2, 40.6, and 23.0 months, respectively; log-rank test, p <0.001). Large (>5 cm) and multiple (â>4) tumors were independently associated with failure to achieve CR after the initial TACE (both p <0.05). Conclusion Both the initial and the best response predicts OS effectively. However, achievement of treatment response at an early time point is still the most robust predictor for favorable outcomes.
AB - Backgrounds & Aims The aim of this study is to evaluate the prognostic significances of not only the initial and the best response during repeated transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC), but if eligible, also the time point of achieving treatment responses. Methods Three hundred and fourteen treatment-naïve patients with well-preserved liver function undergoing TACE were recruited. Treatment responses were assessed using modified Response Evaluation Criteria in Solid Tumors. Overall survival (OS) was analyzed using Kaplan-Meier methods, and Cox regression analysis was performed for multivariate analysis. Results After adjusting other variables, objective response (complete response [CR] and partial response [PR]) as the initial response (adjusted hazard ratio [HR] 0.410) and the best response (adjusted HR 0.335) had independent prognostic significances for OS, respectively (both p <0.001). Objective responders as the initial response had the longest OS, followed by patients who subsequently achieved objective response after at least two sessions and those who did not achieve objective response during treatment course eventually (52.6, 27.0, and 10.8 months, respectively; log-rank test, p <0.001). Likewise, patients with CR as the initial response had the longest OS, followed by those who subsequently achieved CR after at least two sessions and those who achieved PR as the best response (70.2, 40.6, and 23.0 months, respectively; log-rank test, p <0.001). Large (>5 cm) and multiple (â>4) tumors were independently associated with failure to achieve CR after the initial TACE (both p <0.05). Conclusion Both the initial and the best response predicts OS effectively. However, achievement of treatment response at an early time point is still the most robust predictor for favorable outcomes.
UR - http://www.scopus.com/inward/record.url?scp=84929606152&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84929606152&partnerID=8YFLogxK
U2 - 10.1016/j.jhep.2015.01.022
DO - 10.1016/j.jhep.2015.01.022
M3 - Article
C2 - 25637785
AN - SCOPUS:84929606152
VL - 62
SP - 1304
EP - 1310
JO - Journal of Hepatology
JF - Journal of Hepatology
SN - 0168-8278
IS - 6
M1 - 5525
ER -